GSI 250 (Viread 250 mg)

Generic Name: tenofovir

Pill imprint GSI 250 has been identified as Viread 250 mg.

Viread is used in the treatment of hepatitis b; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Viread 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Viread

Generic Name:

tenofovir

Imprint:

GSI 250

Strength:

250 mg

Color:

White

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Gilead Sciences, Inc.

National Drug Code (NDC):

61958-0406

Inactive Ingredients:

corn starch
croscarmellose sodium
lactose monohydrate
microcrystalline cellulose
magnesium stearate
titanium dioxide
triacetin
hypromellose 2910 (15000 mPa.s)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.